[CONTROL AND PREVENTION OF POSTOPERATIVE INFLAMMATION PHENOMENA WITH A NEW ANTIPHLOGISTIC AGENT (TANDERIL)].
D006801:Humans; D007249:Inflammation; D010036:Otolaryngology; D010113:Oxyphenbutazone; D011183:Postoperative Complications; D011184:Postoperative Period
D010113:Oxyphenbutazone
INFLAMMATION; OTORHINOLARYNGOLOGY; OXYPHENBUTAZONE; POSTOPERATIVE COMPLICATIONS
BEKAEMPFUNG UND VERHUETUNG POSTOPERATIVER ENTZUENDUNGSERSCHEINUNGEN MIT EINEM NEUEN ANTIPHLOGISTICUM (TANDERIL)